Export policy of API; Remdesivir; Remdesivir Active; DGFT;

Notification No. 56/2015-2020 Dated February 24th, 2022

The Directorate General of Foreign Trade (DGFT) has amended the export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API), Amphotericin-B injections, Enoxaparin (Formulation and API) and Intra-Venous Immunoglobulin (IVIG) (Formulation and API).

Now, the export policy has been revised to ‘Free’ from existing policy of ‘Restricted’ with immediate effect. In this regard, notification has been issued.

Disclaimer: The content/information published on the website is only for general information of the user and shall not be construed as legal advice. While the Taxmann has exercised reasonable efforts to ensure the veracity of information/content published, Taxmann shall be under no liability in any manner whatsoever for incorrect information, if any.

Source link